Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
J Postgrad Med ; 2008 Oct-Dec; 54(4): 332-4
Article in English | IMSEAR | ID: sea-116231

ABSTRACT

Nicolau syndrome (NS) is a rare complication of an intramuscular injection characterized by severe pain, skin discoloration, and varying levels of tissue necrosis. The case outcomes vary from atrophic ulcers and severe pain to sepsis and limb amputation. We describe a case of a seven-year-old boy with diagnosis of NS after intramuscular benzathine penicillin injection to the ventrolateral aspect of the left thigh. Characteristic violaceous discoloration of skin and immediate injection site pain identified it as a case of NS. The case was complicated by rapid progression of compartment syndrome of the lower limb, proceeding to acute renal failure and death. Associated compartment syndrome can be postulated as a poor prognostic factor for NS.


Subject(s)
Child , Compartment Syndromes/etiology , Drug Eruptions/complications , Fatal Outcome , Humans , Injections, Intramuscular/adverse effects , Acute Kidney Injury/etiology , Male , Pain/chemically induced , Penicillin G Benzathine/administration & dosage , Skin Diseases, Vascular/chemically induced , Skin Pigmentation/drug effects , Syndrome , Thigh
2.
Arq. neuropsiquiatr ; 58(2B): 556-9, jun. 2000. ilus
Article in Portuguese | LILACS | ID: lil-264460

ABSTRACT

Interferon-B (IFN-beta) é usado no tratamento de esclerose múltipla (EM). Descrevemos o caso de uma mulher com EM que apresentou fenômeno de Raynaud grave, livedo reticular e necrose digital duas semanas após tratamento com IFN-beta. Os sintomas melhoraram após suspensão do IFN-beta e início de anticoagulação associada a ciclofosfamida e corticóide. Fenômeno de Raynaud é um efeito colateral provável da terapia com IFN-beta para EM.


Subject(s)
Humans , Female , Middle Aged , Adjuvants, Immunologic/adverse effects , Interferon-beta/adverse effects , Multiple Sclerosis/drug therapy , Raynaud Disease/chemically induced , Adjuvants, Immunologic/therapeutic use , Anticoagulants/therapeutic use , Drug Therapy, Combination , Fingers/pathology , Glucocorticoids/therapeutic use , Immunosuppressive Agents/therapeutic use , Interferon-beta/therapeutic use , Necrosis , Raynaud Disease/drug therapy , Raynaud Disease/pathology , Skin Diseases, Vascular/chemically induced , Skin Diseases, Vascular/drug therapy , Skin Diseases, Vascular/pathology
SELECTION OF CITATIONS
SEARCH DETAIL